Skip to main content



The Broad Institute has published the first volume of its Cancer Cell Line Encyclopedia, a database of cancer knowledge that senior Broad researcher Levi Garraway calls "a preclinical resource that could guide clinical trials," in a press release from the institute. The CCLE — which Broad developed and recently published in Nature in collaboration with the Dana-Farber Cancer Institute, the Genomics Institute of the Novartis Foundation, and the Novartis Institutes for Biomedical Research — is a publicly available resource . "The CCLE integrates gene expression, chromosomal copy number, and massively parallel sequencing data from almost 1,000 human cancer cell lines together with pharmacological profiles for 24 anticancer drugs across roughly half of these cell lines," the Broad says. "The scale of the project allows greater depth of genetic characterization and pharmacological annotation than previously possible with fewer cell lines." Broad's Todd Golub says that the CCLE will "catalyze discoveries throughout the cancer research community," the press release adds.

Though there is optimism about what the CCLE will mean for cancer research, Nature Medicine's Spoonful of Medicine blog sounded a note of caution. The CCLE will allow researchers to identify and test cell lines with mutations like those found in specific patients, says the blog's Rebecca Hersher. But some experts say the cell-line data cannot replace testing in animal models. Validation models are always a necessity, MD Anderson Cancer Center's Lee Ellis tells Hersher. Cell line data is a first step, he adds, but it isn't the only testing needed to bring a drug into the clinic.

Our sister publication GenomeWeb Daily News has more on the CCLE.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.